Because HGF may be centrally involved in CNS autoimmunity, the induction of HGF production by IFN-β might contribute to the beneficial effects of IFN–β therapy in RRMS patients. This evidence concerns the gene IFNB1 and relapsing-remitting multiple sclerosis.